{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "39043734", "DateCompleted": {"Year": "2024", "Month": "07", "Day": "23"}, "DateRevised": {"Year": "2024", "Month": "08", "Day": "05"}, "Article": {"Language": ["eng"], "ELocationID": ["16990", "10.1038/s41598-024-67384-0"], "ArticleDate": [{"Year": "2024", "Month": "07", "Day": "23"}], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "14", "Issue": "1", "PubDate": {"Year": "2024", "Month": "Jul", "Day": "23"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "Extraction optimization and reactivity of 7\u03b1-acetoxy-6\u03b2-hydroxyroyleanone and ability of its derivatives to modulate PKC isoforms.", "Pagination": {"StartPage": "16990", "MedlinePgn": "16990"}, "Abstract": {"AbstractText": ["Protein kinase C is a family of kinases that play important roles in carcinogenesis. Medicinal plants from Plectranthus spp. (Lamiaceae) are a well-known source of interesting abietanes, such as 7\u03b1-acetoxy-6\u03b2-hydroxyroyleanone (Roy). This study aimed to extract and isolate Roy from P. grandidentatus G\u00fcrke, comparing two extraction methods (CO<sub>2</sub> supercritical and ultrasound-assisted acetonic extraction), and design new royleanone derivatives for PKC modulation focusing on breast cancer therapy. The concentration of Roy in the extracts was determined by HPLC-DAD. The supercritical extraction method yielded 3.6% w/w, with the presence of 42.7\u00a0\u03bcg\u00a0mg<sup>-1</sup> of Roy (yield of 0.13%), while ultrasound-assisted acetonic extraction yielded 2.3% w/w, with the presence of 55.2\u00a0\u03bcg\u00a0mg<sup>-1</sup> of Roy (yield of 0.15%). The reactivity of Roy was investigated aiming at synthetizing new ester derivatives through standard benzoylation and esterification reactions. The benzoylated (Roy-12-Bz) and acetylated (Roy-12-Ac) derivatives in the C12 position were consistently prepared with overall good yields (33-86%). These results indicate the 12-OH position as the most reactive for esterification, affording derivatives under mild conditions. The reported di-benzoylated (RoyBz) and di-acetylated (RoyAc) derivatives were also synthesized after increasing the temperature (50\u00a0\u00b0C), reaction time, and using an excess of reagents. The cytotoxic potential of Roy and its derivatives was assessed against breast cancer cell lines, with RoyBz emerging as the most promising compound. Derivatization at position C-12 did not offer advantages over di-esterification at positions C-12 and C-6 or over the parent compound Roy and the presence of aromatic groups favored cytotoxicity. Evaluation of royleanones as PKC-\u03b1, \u03b2I, \u03b4, \u03b5, and \u03b6 activators revealed DeRoy's efficacy across all isoforms, while RoyPr showed promising activation of PKC-\u03b4 but not PKC-\u03b6, highlighting the influence of slight structural changes on isoform selectivity. Molecular docking analysis emphasized the importance of microenvironmental factors in isoform specificity, underscoring the complexity of PKC modulation and the need for further exploration."], "CopyrightInformation": "\u00a9 2024. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CBIOS - Center for Research in Biosciences and Health Technologies, Universidade Lus\u00f3fona, 1749-024, Lisboa, Portugal."}, {"Identifier": [], "Affiliation": "Research Institute for Medicines (iMed.ULisboa), Faculty of Farmacy, Universidade de Lisboa, 1649-003, Lisboa, Portugal."}], "LastName": "Isca", "ForeName": "Vera M S", "Initials": "VMS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CBIOS - Center for Research in Biosciences and Health Technologies, Universidade Lus\u00f3fona, 1749-024, Lisboa, Portugal."}, {"Identifier": [], "Affiliation": "Departamento de Ciencias Biom\u00e9dicas (\u00c1rea de Farmacolog\u00eda), Nuevos agentes antitumorales, Acci\u00f3n t\u00f3xica sobre c\u00e9lulas leuc\u00e9micas, Facultad de Farmacia, Universidad de Alcal\u00e1 de Henares, Ctra. Madrid-Barcelona Km. 33, 600 28805, Alcal\u00e1 de Henares, Madrid, Spain."}], "LastName": "Bangay", "ForeName": "Gabrielle", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CBIOS - Center for Research in Biosciences and Health Technologies, Universidade Lus\u00f3fona, 1749-024, Lisboa, Portugal."}, {"Identifier": [], "Affiliation": "Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, via Celoria 2, 20133, Milan, Italy."}], "LastName": "Princiotto", "ForeName": "Salvatore", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "LAQV/REQUIMTE, Laborat\u00f3rio de Microbiologia, Departamento de Ci\u00eancias Biol\u00f3gicas, Faculdade de Farm\u00e1cia, Universidade do Porto, 4050-313, Porto, Portugal."}], "LastName": "Sara\u00edva", "ForeName": "Luc\u00edlia", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CBIOS - Center for Research in Biosciences and Health Technologies, Universidade Lus\u00f3fona, 1749-024, Lisboa, Portugal."}], "LastName": "Dos Santos", "ForeName": "Daniel J V A", "Initials": "DJVA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chemistry, University of Tartu, 54011, Tartu, Estonia. alfonso.tlatoani.garcia.sosa@ut.ee."}], "LastName": "Garc\u00eda-Sosa", "ForeName": "Alfonso T", "Initials": "AT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CBIOS - Center for Research in Biosciences and Health Technologies, Universidade Lus\u00f3fona, 1749-024, Lisboa, Portugal. patricia.rijo@ulusofona.pt."}, {"Identifier": [], "Affiliation": "Research Institute for Medicines (iMed.ULisboa), Faculty of Farmacy, Universidade de Lisboa, 1649-003, Lisboa, Portugal. patricia.rijo@ulusofona.pt."}], "LastName": "Rijo", "ForeName": "Patr\u00edcia", "Initials": "P"}], "GrantList": [{"GrantID": "UIDB/50006/2020 DOI 10.54499/UIDB/50006/2020, DOI 10.54499/UIDP/04567/2020 and DOI 10.54499/UIDB/04567/2020 and PhD grant SFRH/BD/137671/2018", "Agency": "Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia", "Country": ""}, {"GrantID": "PRG1509", "Agency": "Estonian Research Council", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "EC 2.7.11.13", "NameOfSubstance": "Protein Kinase C"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Isoenzymes"}, {"RegistryNumber": "0", "NameOfSubstance": "7alpha-acetoxy-6beta-hydroxyroyleanone"}, {"RegistryNumber": "0", "NameOfSubstance": "Diterpenes"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Protein Kinase C"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["metabolism"], "DescriptorName": "Isoenzymes"}, {"QualifierName": [], "DescriptorName": "MCF-7 Cells"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Diterpenes"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Garcia, C. et al. Naturally occurring plectranthus-derived diterpenes with antitumoral activities. Curr. Pharm. Des.24, 4207\u20134236 (2018). 10.2174/1381612825666190115144241", "ArticleIdList": ["10.2174/1381612825666190115144241", "30644340"]}, {"Citation": "He, S., Li, Q., Huang, Q. & Cheng, J. Targeting protein kinase C for cancer therapy. Cancers10.3390/cancers14051104 (2022). 10.3390/cancers14051104", "ArticleIdList": ["10.3390/cancers14051104", "PMC8909172", "35267413"]}, {"Citation": "Tarafdar, A. & Michie, A. M. Protein kinase C in cellular transformation: A valid target for therapy?. Biochem. Soc. Trans.42, 1556\u20131562 (2014). 10.1042/BST20140255", "ArticleIdList": ["10.1042/BST20140255", "PMC4613511", "25399570"]}, {"Citation": "Matias, D. et al. Chapter 2\u2014Natural products as lead protein kinase C modulators for cancer therapy. In Studies in Natural Products Chemistry Vol. 50 (ed. Atta-ur-Rahman) 45\u201379 (Elseiver, 2016)."}, {"Citation": "Bessa, C. et al. Discovery of a small-molecule protein kinase C\u03b4-selective activator with promising application in colon cancer therapy article. Cell Death Dis.9 (2018).", "ArticleIdList": ["PMC5833815", "29348560"]}, {"Citation": "Isca, V. M. S. et al. Activity to breast cancer cell lines of different malignancy and predicted interaction. Int. J. Mol. Sci.21, 3671 (2020). 10.3390/ijms21103671", "ArticleIdList": ["10.3390/ijms21103671", "PMC7279380", "32456148"]}, {"Citation": "Newton, A. C. Protein kinase C as a tumor suppressor. Semin. Cancer Biol.48, 18\u201326 (2018). 10.1016/j.semcancer.2017.04.017", "ArticleIdList": ["10.1016/j.semcancer.2017.04.017", "PMC5668200", "28476658"]}, {"Citation": "Garg, R. et al. Protein kinase C and cancer: What we know and what we do not. Oncogene33, 5225\u20135237 (2014). 10.1038/onc.2013.524", "ArticleIdList": ["10.1038/onc.2013.524", "PMC4435965", "24336328"]}, {"Citation": "M\u00fcller, G. et al. PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. EMBO J.14, 1961\u20131969 (1995). 10.1002/j.1460-2075.1995.tb07188.x", "ArticleIdList": ["10.1002/j.1460-2075.1995.tb07188.x", "PMC398295", "7744003"]}, {"Citation": "Cooke, M., Magimaidas, A., Casado-Medrano, V. & Kazanietz, M. G. Protein kinase C in cancer: The top five unanswered questions. Mol. Carcinog.56, 1531\u20131542 (2017). 10.1002/mc.22617", "ArticleIdList": ["10.1002/mc.22617", "PMC5423816", "28112438"]}, {"Citation": "Mochly-Rosen, D., Das, K. & Grimes, K. V. Protein kinase C, an elusive therapeutic target?. Nat. Rev. Drug Discov.11, 937 (2012). 10.1038/nrd3871", "ArticleIdList": ["10.1038/nrd3871", "PMC3760692", "23197040"]}, {"Citation": "Ringvold, H. C. & Khalil, R. A. Chapter Six\u2014Protein kinase C as regulator of vascular smooth muscle function and potential target in vascular disorders. In Vascular pharmacology (ed. Khalil, R. A. B. T.-A. in P.) vol. 78 203\u2013301 (Academic Press, 2017).", "ArticleIdList": ["PMC5319769", "28212798"]}, {"Citation": "Mochly-Rosen, D. & Gordon, A. S. Anchoring proteins for protein kinase C: a means for isozyme selectivity. FASEB J.12, 35\u201342 (1998). 10.1096/fasebj.12.1.35", "ArticleIdList": ["10.1096/fasebj.12.1.35", "9438408"]}, {"Citation": "Churchill, E. N., Qvit, N. & Mochly-Rosen, D. Rationally designed peptide regulators of protein kinase C. Trends Endocrinol. Metab.20, 25\u201333 (2009). 10.1016/j.tem.2008.10.002", "ArticleIdList": ["10.1016/j.tem.2008.10.002", "PMC2714361", "19056296"]}, {"Citation": "Kheifets, V. & Mochly-Rosen, D. Insight into intra- and inter-molecular interactions of PKC: Design of specific modulators of kinase function. Pharmacol. Res.55, 467\u2013476 (2007). 10.1016/j.phrs.2007.04.014", "ArticleIdList": ["10.1016/j.phrs.2007.04.014", "PMC2834269", "17580120"]}, {"Citation": "Griner, E. M. & Kazanietz, M. G. Protein kinase C and other diacylglycerol effectors in cancer. Nat. Rev. Cancer7, 281\u2013294 (2007). 10.1038/nrc2110", "ArticleIdList": ["10.1038/nrc2110", "17384583"]}, {"Citation": "Isakov, N. Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression. Semin. Cancer Biol.48, 36\u201352 (2018). 10.1016/j.semcancer.2017.04.012", "ArticleIdList": ["10.1016/j.semcancer.2017.04.012", "28571764"]}, {"Citation": "Koivunen, J., Aaltonen, V. & Peltonen, J. Protein kinase C (PKC) family in cancer progression. Cancer Lett.235, 1\u201310. 10.1016/j.canlet.2005.03.033 (2006). 10.1016/j.canlet.2005.03.033", "ArticleIdList": ["10.1016/j.canlet.2005.03.033", "15907369"]}, {"Citation": "Gauthier, M., Torretto, C., Ly, J., Francescutti, V. & O\u2019Day, D. Protein kinase C\u03b1 negatively regulates cell spreading and motility in MDA-MB-231 human breast cancer cells downstream of epidermal growth factor receptor. Biochem. Biophys. Res. Commun.307, 839\u2013846 (2003). 10.1016/S0006-291X(03)01273-7", "ArticleIdList": ["10.1016/S0006-291X(03)01273-7", "12878187"]}, {"Citation": "Martiny-Baron, G. & Fabbro, D. Classical PKC isoforms in cancer. Pharmacol. Res.55, 477\u2013486 (2007). 10.1016/j.phrs.2007.04.001", "ArticleIdList": ["10.1016/j.phrs.2007.04.001", "17548205"]}, {"Citation": "Ainsworth, P. D., Winstanley, J. H. R., Pearson, J. M., Bishop, H. M. & Garrod, D. R. Protein kinase C alpha expression in normal breast, ductal carcinoma in situ and invasive ductal carcinoma. Eur. J. Cancer40, 2269\u20132273 (2004). 10.1016/j.ejca.2004.06.027", "ArticleIdList": ["10.1016/j.ejca.2004.06.027", "15454252"]}, {"Citation": "Kerfoot, C., Huang, W. & Rotenberg, S. A. Immunohistochemical analysis of advanced human breast carcinomas reveals downregulation of protein kinase C\u03b1. J. Histochem. Cytochem.52, 419\u2013422 (2004). 10.1177/002215540405200314", "ArticleIdList": ["10.1177/002215540405200314", "14966210"]}, {"Citation": "Ladeiras, D. et al. Reactivity of diterpenoid quinones: Royleanones. Curr. Pharm. Des.22, 1682\u20131714 (2016). 10.2174/1381612822666151211094521", "ArticleIdList": ["10.2174/1381612822666151211094521", "26654590"]}, {"Citation": "Bernardes, C. E. S. et al. Extraction optimization, structural and thermal characterization of the antimicrobial abietane 7\u03b1-acetoxy-6\u03b2-hydroxyroyleanone. Mol. Pharm.5, 1412\u20131419 (2018).10.1021/acs.molpharmaceut.7b00892", "ArticleIdList": ["10.1021/acs.molpharmaceut.7b00892", "29494159"]}, {"Citation": "Marques, C. G. et al. Effect of abietane diterpenes from Plectranthus grandidentatus on the growth of human cancer cell lines. Planta Med.68, 839\u2013840 (2002). 10.1055/s-2002-34407", "ArticleIdList": ["10.1055/s-2002-34407", "12357400"]}, {"Citation": "Kub\u00ednov\u00e1, R. et al. Antimicrobial and enzyme inhibitory activities of the constituents of Plectranthus madagascariensis (Pers.) Benth. J. Enzyme Inhib. Med. Chem.29, 749\u2013752 (2014). 10.3109/14756366.2013.848204", "ArticleIdList": ["10.3109/14756366.2013.848204", "24506206"]}, {"Citation": "Rijo, P., Duarte, A., Francisco, A. P., Semedo-Lemsaddek, T. & Sim\u00f5es, M. F. In vitro antimicrobial activity of royleanone derivatives against gram-positive bacterial pathogens. Phytother. Res.28, 76\u201381 (2014). 10.1002/ptr.4961", "ArticleIdList": ["10.1002/ptr.4961", "23494919"]}, {"Citation": "Cerqueira, F. et al. Effect of abietane diterpenes from Plectranthus grandidentatus on T- and B-lymphocyte proliferation. Bioorg. Med. Chem.12, 217\u2013223 (2004). 10.1016/j.bmc.2003.10.006", "ArticleIdList": ["10.1016/j.bmc.2003.10.006", "14697786"]}, {"Citation": "Garcia, C. et al. Anticancer properties of the abietane diterpene 6,7-dehydroroyleanone obtained by optimized extraction. Future Med. Chem.1, 1177\u20131189 (2018).10.4155/fmc-2017-0239", "ArticleIdList": ["10.4155/fmc-2017-0239", "29749759"]}, {"Citation": "Gazim, Z. C. et al. New natural diterpene-type abietane from Tetradenia riparia essential oil with cytotoxic and antioxidant activities. Molecules19, 514\u2013524 (2014). 10.3390/molecules19010514", "ArticleIdList": ["10.3390/molecules19010514", "PMC6271109", "24451247"]}, {"Citation": "Ndjoubi, K. O. et al. Antimycobacterial, cytotoxic, and antioxidant activities of abietane diterpenoids isolated from Plectranthus madagascariensis. Plants10, 175 (2021). 10.3390/plants10010175", "ArticleIdList": ["10.3390/plants10010175", "PMC7832401", "33477744"]}, {"Citation": "Matias, D. et al. Cytotoxic activity of royleanone diterpenes from Plectranthus madagascariensis Benth. ACS Omega4, 8094\u20138103 (2019). 10.1021/acsomega.9b00512", "ArticleIdList": ["10.1021/acsomega.9b00512", "PMC6648853", "31459900"]}, {"Citation": "Garcia, C. et al. Royleanone derivatives from Plectranthus spp. as a novel class of P-glycoprotein inhibitors. Front. Pharmacol.11, 1711 (2020).10.3389/fphar.2020.557789", "ArticleIdList": ["10.3389/fphar.2020.557789", "PMC7751738", "33364937"]}, {"Citation": "Garcia, C. Isolation, synthesis and nanoencapsulation of cytotoxic compounds from Plectranthus spp. (Doctoral dissertation. Universidad de Alcal\u00e1, Alcal\u00e1 and Universidade Lus\u00f3fona de Humanidades e Tecnologias, Lisbon, 2019)."}, {"Citation": "Rijo, P. Phytochemical Study and Biological Activities of Diterpenes and Derivatives From Plectranthus Species (Universidade de Lisboa, 2010)."}, {"Citation": "Saraiva, L. & Rijo, P. Roy-Bz: A small molecule activator of Protein Kinase C delta\u2014Patent Ref PCT/IB2017/050633 (2017)."}, {"Citation": "Rijo, P. et al. Antimycobacterial Metabolites from Plectranthus: Royleanone derivatives against Mycobacterium tuberculosis strains. Chem. Biodivers.7, 922\u2013932 (2010). 10.1002/cbdv.200900099", "ArticleIdList": ["10.1002/cbdv.200900099", "20397225"]}, {"Citation": "Isca, V. M. S. et al. Molecular docking studies of royleanone diterpenoids from Plectranthus spp. as P-glycoprotein inhibitors. ACS Med. Chem. Lett.11, 839\u2013845 (2020). 10.1021/acsmedchemlett.9b00642", "ArticleIdList": ["10.1021/acsmedchemlett.9b00642", "PMC7236232", "32435393"]}, {"Citation": "Sim\u00f5es, M. F. et al. Two new diterpenoids from Plectranthus species. Phytochem. Lett.3, 221\u2013225 (2010).10.1016/j.phytol.2010.08.002", "ArticleIdList": ["10.1016/j.phytol.2010.08.002"]}, {"Citation": "Hensch, M., R\u00fcedi, P. & Eugster, C. H. Horminon, Taxochinon und weitere Royleanone aus 2 abessinischen Plectranthus-Spezies (Labiatae). Helv. Chim. Acta58, 1921\u20131934 (1975).10.1002/hlca.19750580707", "ArticleIdList": ["10.1002/hlca.19750580707"]}, {"Citation": "Filipe, M. S. et al. Biological activity of 6,7-dehydroxyroyleanone and derivatives obtained from Plectranthus aliciae (Codd) A. J. Paton. ACS Omega9, 18113\u201318118 (2024). 10.1021/acsomega.3c10071", "ArticleIdList": ["10.1021/acsomega.3c10071", "PMC11044231", "38680304"]}, {"Citation": "Burmistrova, O. et al. Antiproliferative activity of abietane diterpenoids against human tumor cells. J. Nat. Prod.76, 1413\u20131423 (2013). 10.1021/np400172k", "ArticleIdList": ["10.1021/np400172k", "23865778"]}, {"Citation": "Dai, X., Cheng, H., Bai, Z. & Li, J. Breast cancer cell line classification and its relevance with breast tumor subtyping. J. Cancer8, 3131 (2017). 10.7150/jca.18457", "ArticleIdList": ["10.7150/jca.18457", "PMC5665029", "29158785"]}, {"Citation": "Indrayanto, G., Putra, G. S. & Suhud, F. Chapter six\u2014Validation of in-vitro bioassay methods: Application in herbal drug research. In Profiles of Drug Substances, Excipients and Related Methodology Vol. 46 (ed. Al-Majed, A. A.) 273\u2013307 (Academic Press, 2021).", "ArticleIdList": ["33461699"]}, {"Citation": "Wong, C. C., Cheng, K.-W. & Rigas, B. Preclinical predictors of anticancer drug efficacy: Critical assessment with emphasis on whether nanomolar potency should be required of candidate agents. J. Pharmacol. Exp. Ther.341, 572\u2013578 (2012). 10.1124/jpet.112.191957", "ArticleIdList": ["10.1124/jpet.112.191957", "PMC3362883", "22448039"]}, {"Citation": "Forli, S. et al. Computational protein\u2013ligand docking and virtual drug screening with the AutoDock suite. Nat. Protoc.11, 905\u2013919 (2016). 10.1038/nprot.2016.051", "ArticleIdList": ["10.1038/nprot.2016.051", "PMC4868550", "27077332"]}, {"Citation": "Protein Data Bank. https://www.rcsb.org/structure/2ELI."}, {"Citation": "Orientations of Proteins in Membranes. opm.phar.umich.edu."}, {"Citation": "The Plant List. Version 1.1. http://www.theplantlist.org/ (2013)."}, {"Citation": "Pereira, P., Bernardo-Gil, G., Cebola, M.-J., Mauricio, E. & Romano, A. Supercritical fluid extracts with antioxidant and antimicrobial activities from myrtle (Myrtus communis L.) leaves. Response surface optimization. J. Supercrit. Fluids83, 57\u201364 (2013).10.1016/j.supflu.2013.08.010", "ArticleIdList": ["10.1016/j.supflu.2013.08.010"]}, {"Citation": "European Medicines Agency. Validation of Analytical Procedures: Text and Methodology (CPMP/ICH/381/95). http://www.emea.eu.int (1995)."}, {"Citation": "Molecular Operating Environment (MOE) v.2020.0901 (Chemical Computing Group Inc, 2020)."}, {"Citation": "Rice, L. J., Brits, G. J., Potgieter, C. J. & Van Staden, J. Plectranthus: A plant for the future?. S. Afr. J. Bot.77, 947\u2013959 (2011).10.1016/j.sajb.2011.07.001", "ArticleIdList": ["10.1016/j.sajb.2011.07.001"]}, {"Citation": "Lukhoba, C. W., Simmonds, M. S. J. & Paton, A. J. Plectranthus: A review of ethnobotanical uses. J. Ethnopharmacol.103, 1\u201324. 10.1016/j.jep.2005.09.011 (2006). 10.1016/j.jep.2005.09.011", "ArticleIdList": ["10.1016/j.jep.2005.09.011", "16289602"]}]}], "History": [{"Year": "2023", "Month": "1", "Day": "8"}, {"Year": "2024", "Month": "7", "Day": "10"}, {"Year": "2024", "Month": "7", "Day": "24", "Hour": "0", "Minute": "43"}, {"Year": "2024", "Month": "7", "Day": "24", "Hour": "0", "Minute": "42"}, {"Year": "2024", "Month": "7", "Day": "23", "Hour": "23", "Minute": "20"}, {"Year": "2024", "Month": "7", "Day": "23"}], "PublicationStatus": "epublish", "ArticleIdList": ["39043734", "PMC11266714", "10.1038/s41598-024-67384-0", "10.1038/s41598-024-67384-0"]}}]}